We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

February 1, 2006

Merado v. AstraZeneca Pharmaceuticals LP et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. September 25, 2012

    AstraZeneca To Pay $11M To Settle Toprol-XL Antitrust Claims

    AstraZeneca Pharmaceuticals LP on Tuesday agreed to pay $11 million to settle claims by a proposed class of indirect purchasers of hypertension drug Toprol-XL that the drugmaker used sham patent litigation to prolong a monopoly on the drug by delaying generic versions.

1 other articles on this case. View all »


To view the parties, register now.